HSCSW
HeartSciences Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.07
+44.89%Income statement
| Metric | TTM | 2025 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.3K | 4.3K | 4.3K | 18.6K | 5.2K |
| Cost of Revenue | 133.1K | 133.1K | 129.8K | 101.2K | 29.7K |
| Gross Profit | (128.8K) | (128.8K) | (125.5K) | (82.6K) | (24.6K) |
| Operating Expenses | |||||
| R&D Expense | — | 2.8B | 4.4M | 2.9M | 2.5M |
| SG&A Expense | — | 5.6B | 3.8M | 3.3M | 3.6M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 8.3M | (8.4B) | — | — | — |
| Total Operating Expenses | 8.3M | 8.3M | 8.2M | 6.2M | 6.1M |
| Cost and Expenses | 8.4M | 8.4M | 8.4M | 6.3M | 6.1M |
| Operating Income (EBIT) | (8.4M) | (8.4M) | (8.4M) | (6.3M) | (6.1M) |
| Non-Operating | |||||
| Interest Income | — | — | 87.8K | — | — |
| Interest Expense | 753.0K | 753.0K | 500.5K | 354.1K | 243.2K |
| Net Interest Income | (753.0K) | (753.0K) | (412.7K) | (354.1K) | (243.2K) |
| Other Non-Op Income/Expense | (729.0K) | (729.0K) | (412.7K) | (299.4K) | (241.3K) |
| Non-Operating Income (excl Interest) | (10.2K) | — | — | (54.6K) | (1.8K) |
| EBT (Pre-Tax Income) | (9.1M) | (9.1M) | (8.8M) | (6.6M) | (6.4M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (9.1M) | (9.1M) | (8.8M) | (6.6M) | (6.4M) |
| Earnings from Cont. Ops | (9.1M) | (9.1M) | (8.8M) | (6.6M) | (6.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (9.1M) | (9.1M) | (8.8M) | (6.6M) | (6.4M) |
| Per Share | |||||
| Basic EPS | ($3.92) | ($3.48) | ($9.34) | ($18.74) | ($79.92) |
| Diluted EPS | ($3.92) | ($3.48) | ($9.34) | ($18.74) | ($79.92) |
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.05 | $0.06 |
| Shares | |||||
| Basic Shares Outstanding | 3.2M | 2.6M | 938257 | 352520 | 79505 |
| Diluted Shares Outstanding | 3.2M | 2.6M | 938257 | 352520 | 79505 |
| Profitability Metrics | |||||
| EBITDA | (8.4M) | (8.4M) | (8.2M) | (6.2M) | (6.1M) |
| D&A | — | — | 128.0K | 95.1K | 26.9K |
| EBIT | (8.4M) | (8.4M) | (8.4M) | (6.3M) | (6.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jan 1, 2026